InsiderSignal.AI

InsiderSignal.ai

SGP - Spyglass Pharma, Inc.

Insider Purchase by Nielsen Kirk G. (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Nielsen Kirk G., serving as Dir at Spyglass Pharma, Inc. (SGP), purchased 165,000 shares at $16.00 per share, for a total transaction value of $2,640,000.00. Following this transaction, Nielsen Kirk G. now holds 3,310,619 shares of SGP.

This purchase represents a 5.00% increase in Nielsen Kirk G.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 10, 2026, 1 day after the trade was made.

Nielsen Kirk G.

Dir

Kirk G. Nielsen is a seasoned venture capital executive and board director in the medtech sector. He serves as Managing Partner at Vensana Capital since January 2019, which he co-founded, and as Managing Director at Versant Ventures since January 2011, leading the firm's medtech practice.[[1]](https://fintool.com/app/research/companies/CVRX/people/kirk-nielsen)[[5]](https://www.vensanacap.com/people/kirk-nielsen/) Previously at Medtronic in Cardiac Rhythm Management sales and marketing, and earlier as a consultant at Bain & Company and professional hockey player, Nielsen holds an M.B.A. from Harvard Business School and an A.B. from Harvard College.[[1]](https://fintool.com/app/research/companies/CVRX/people/kirk-nielsen)[[5]](https://www.vensanacap.com/people/kirk-nielsen/) Nielsen is a Director at SpyGlass Pharma, Inc. (SGP), where he recently purchased 165,000 shares on February 9, 2026, signaling confidence in the company.[[2]](https://www.streetinsider.com/SEC+Filings/Form+4+SpyGlass+Pharma,+Inc.+For:+Feb+09+Filed+by:+Nielsen+Kirk+G./25977356.html)[[3]](https://www.tipranks.com/news/insider-trading/major-insider-moves-signal-growing-confidence-in-spyglass-pharma-insider-trading)[[4]](https://www.spyglasspharma.com/about-us/) He also serves as an independent director at CVRx, Inc. (CVRX) since July 2020 (Class III, NCG Committee Chair, Audit member), previously as Independent Lead Director until February 2024, and on boards of multiple medtech firms including Alleviant Medical, Elucent Medical, and others.[[1]](https://fintool.com/app/research/companies/CVRX/people/kirk-nielsen)[[4]](https://www.spyglasspharma.com/about-us/) His investments include successful exits like Inari Medical (IPO) and SpyGlass Pharma.[[1]](https://fintool.com/app/research/companies/CVRX/people/kirk-nielsen)[[5]](https://www.vensanacap.com/people/kirk-nielsen/)

View full insider profile →

Trade Price

$16.00

Quantity

165,000

Total Value

$2,640,000.00

Shares Owned

3,310,619

Trade Date

Monday, February 9, 2026

13 days ago

SEC Filing Date

Tuesday, February 10, 2026

Filed 1 day after trade

About Spyglass Pharma, Inc.

Company Overview

No company information available
View news mentioning SGP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3871651

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime